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Editorial
Father of the Implantable
Cardioverter/Deﬁbrillator
Dr. Michel Mirowski
The implantation of an implantable cardioverter/deﬁbrillator (ICD) has become the ﬁrst
line of therapy for ventricular tachycardia/ﬁbrillation in patients with structural heart
disease. Large clinical trials have shown that the survival rate of patients with an ICD is
better than that of patients treated with arrhythmic drugs.
This implantable device was developed by Dr. Michel Mirowski. When he came to
Japan, he told us how the concept of the ICD developed in his mind. According to him, the
concept of implanting a deﬁbrillator in humans emerged after experiencing the tragic death
of his friend, Dr. Harry Heller, Chief of Medicine. Dr. Heller had been hospitalized several
times with recurrent episodes of ventricular arrhythmia. At that time, the use of an external
cardiac deﬁbrillator in the coronary care unit was the only means for saving patients with
serious ventricular tachyarrhythmia. Thus, ventricular ﬁbrillation occurring outside the
hospital was usually fatal. After much thought, Dr. Mirowski came to the conclusion that
his friend death could have been avoided if a deﬁbrillator had been implanted. In his mind,
the concept of implanting a deﬁbrillator was not unrealistic because implantable
pacemakers had been used for sometime for patients with bradycardia. However, to the
majority of cardiologists in 1960, this concept was far from realistic.
To realize his goal of developing a deﬁbrillator that is small enough to implant in
humans, Dr. Mirowski went to Sinai Hospital in Baltimore. Miniaturizing the deﬁbrillator
to a size that could be implanted and creating a system that could deliver shock through
an intravenous lead were diﬃcult tasks. But with the help of clinical engineering and animal
research faculties in Sinai Hospital, he was able to construct a prototype automatic
deﬁbrillator that was implanted in a dog in 1975. Experiments in dogs were successful, but
most professionals in medical and engineering communities were skeptical that a workable
device would be possible in man. The ﬁrst implantation of an ICD device in a human took
place in 1980 at Johns Hopkins Hospital after a decade of research and animal exper-
imentation. ICD devices were subsequently implanted in 37 patients. Results showed that
sudden death rate in patients in whom an ICD had been implanted was much lower than that
predicted from data reported in the literature.
Dr. Mirowski died in 1990, but his concept of implanting of an ICD in man has since
been further developed and the device has been continuously reﬁned. Modern ICD systems
now combine bradycardia pacing, antitachycardia pacing and a deﬁbrillatory option in one
single device.
Finally, the most impressive words I heard from him were that ‘Don’t give up; there is
always some way of solving the problem’. I believe that this belief was his power source for
developing the new device that has saved many patients with serious ventricular arrhythmia
in spite of various diﬃculties and strong opposition.
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